High-risk prematurity--progestin treatment and steroid studies

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Endocrinology

Background:

• Preterm birth remains a leading cause of neonatal morbidity and mortality.
• The progesterone block theory suggests progesterone plays a crucial role in maintaining pregnancy.
• Identifying high-risk patients and effective interventions for preterm labor is critical.

Purpose of the Study:

• To evaluate the efficacy of 17 alpha-hydroxyprogesterone caproate (17 alpha-OHP-C) in preventing premature labor.
• To investigate the relationship between plasma steroid levels and preterm labor onset.
• To explore the mechanism of action of 17 alpha-OHP-C in high-risk pregnancies.

Main Methods:

• A clinical study involving 70 high-risk patients, with a treatment group receiving 17 alpha-OHP-C and a control group receiving placebo or no treatment.
• Sequential plasma steroid levels (progesterone, 17 alpha-hydroxyprogesterone, estradiol, cortisol) were measured in 21 patients.
• Preterm birth rates and perinatal mortality rates were compared between groups.

Main Results:

• The 17 alpha-OHP-C treated group showed significantly lower prematurity rates (12.8%) and perinatal mortality rates (5%) compared to the placebo/untreated group (40.9% and 25%).
• Low plasma progesterone (P) and 17 alpha-hydroxyprogesterone (17 alpha-OHP) levels were observed weeks before preterm labor onset.
• Successful 17 alpha-OHP-C treatment correlated with elevated P levels, while estradiol (E2) and cortisol (C) levels showed no significant changes.

Conclusions:

• 17 alpha-hydroxyprogesterone caproate is effective in reducing preterm birth and perinatal mortality in high-risk populations.
• Plasma progesterone and 17 alpha-hydroxyprogesterone levels are potential biomarkers for predicting preterm labor.
• The findings support the progesterone block theory in the context of preterm delivery.